Technical Analysis for CNAT - Conatus Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade F 4.13 2.48% 0.10
CNAT closed up 2.48 percent on Wednesday, November 22, 2017, on 61 percent of normal volume.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical CNAT trend table...

Date Alert Name Type % Chg
Nov 17 MACD Bullish Signal Line Cross Bullish -2.13%
Nov 15 Spinning Top Other 3.77%
Nov 15 Stochastic Reached Oversold Other 3.77%
Nov 14 NR7 Range Contraction 1.23%
Nov 14 Narrow Range Bar Range Contraction 1.23%
Nov 9 Bullish Engulfing Bullish 0.24%
Nov 8 Hammer Candlestick Bullish 1.47%
Nov 8 Lizard Bullish Bullish Day Trade Setup 1.47%
Nov 7 NR7 Range Contraction 0.00%
Nov 7 New Downtrend Bearish 0.00%

Older signals for CNAT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of medicines to treat liver diseases in the United States. Its products include Emricasan, an orally active caspase protease inhibitor for the treatment of acute-on-chronic liver failure and chronic liver failure, as well as for the patients who have developed liver fibrosis post-orthotopic liver transplant due to Hepatitis C virus infection. The company was founded in 2005 and is headquartered in San Diego, California.
Is CNAT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.4
52 Week Low 1.73
Average Volume 294,198
200-Day Moving Average 5.4948
50-Day Moving Average 4.9681
20-Day Moving Average 4.2705
10-Day Moving Average 4.107
Average True Range 0.2316
ADX 30.52
+DI 14.46
-DI 23.08
Chandelier Exit (Long, 3 ATRs ) 4.4052
Chandelier Exit (Short, 3 ATRs ) 4.5848
Upper Bollinger Band 4.746
Lower Bollinger Band 3.795
Percent B (%b) 0.35
BandWidth 22.269055
MACD Line -0.2588
MACD Signal Line -0.2877
MACD Histogram 0.0289
Fundamentals Value
Market Cap 123.92 Million
Num Shares 30 Million
EPS -0.98
Price-to-Earnings (P/E) Ratio -4.21
Price-to-Sales 7.70
Price-to-Book 4.00
PEG Ratio -0.23
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.39
Resistance 3 (R3) 4.38 4.29 4.34
Resistance 2 (R2) 4.29 4.23 4.29 4.33
Resistance 1 (R1) 4.21 4.18 4.25 4.22 4.31
Pivot Point 4.12 4.12 4.14 4.12 4.12
Support 1 (S1) 4.04 4.06 4.08 4.05 3.95
Support 2 (S2) 3.95 4.01 3.95 3.93
Support 3 (S3) 3.87 3.95 3.92
Support 4 (S4) 3.88